Engine Biosciences

📍 Singapore, Singapore👥 37 employees💰 Last funded 2018
Biotechnology Research🌐 enginebio.com
Website LinkedIn
Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. Our proprietary and patented technologies oriented around deciphering the complexity of biology networks include both high-throughput wet lab experimentation and artificial intelligence algorithms for drug discovery and cellular reprogramming. This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies. We are actively applying the platform internally and with partners across a range of disease indications. In January 2018, we announced the closing of a US$10M seed round from notable biotech and tech institutional investors and are expanding the team.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Engine Biosciences?
Engine Biosciences has 2 investors on record on gritt.io.
When did Engine Biosciences last raise funding?
The most recent investment in Engine Biosciences recorded on gritt.io was in 2018.
What industry is Engine Biosciences in?
Engine Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Engine Biosciences based?
Engine Biosciences is headquartered in Singapore, Singapore.